Chemelot Ventures

ReSolved Technologies are dedicated to increase the circularity of engineering plastics by addressing complex waste streams. They do this by extracting valuable plastics from these difficult-to-recycle waste streams and convert them to recycled material of near-virgin quality that is suited for closed-loop recycling in high-end markets.

Black Bear Carbon BV specializes in converting waste tires into carbon black and green energy, operating primarily in the Netherlands and internationally. Founded in 2010 and based in Nederweert, the company utilizes a circular economy model to transform end-of-life tires into sustainable products. Its carbon black, a form of elemental carbon produced through controlled pyrolysis and partial combustion, is employed in various applications, including tires, technical rubber products, plastics, and paints. Additionally, Black Bear Carbon powers its tire shredding operations with electricity generated on-site, while also supplying excess energy to local industries and grids. By providing a renewable resource that reduces reliance on oil and lowers carbon dioxide emissions, the company promotes environmentally friendly practices in the manufacturing sector.

Health Value Creation is developing two surgical devices, a diagnostic tool and a trocar closure device. The first device helps prevent anastomotic leakages after bowel surgery by predicting the quality of the anastomosis during surgery, thereby reducing post-operative complications and lowering healthcare costs. The second device is a trocar closure device for faster, safer and more secure suturing after laparoscopic surgery, resulting in a reduction of the chances of wound herniation.

Mito Medical is developing an innovative diagnostic device that measures vascularity (blood-vessel formation) in the breast and aims to replace the often harmful X-ray cancer screening examination. This technology enables pain-free breast cancer screening with no adverse health risks in both younger and older women, at an earlier stage than is currently the case.

TripleMed is focused on developing minimally invasive solutions for the treatment of aortic aneurysms. The company's primary product employs an elastic polymer that is designed to fill and cure within the aneurysm sac, effectively preventing blood from entering the aneurysm while allowing blood to flow through a channel to other arteries. This innovative approach enables healthcare professionals to perform treatments through percutaneous endovascular procedures, minimizing the need for open surgery. By offering a more effective and durable solution for addressing aortic aneurysms, TripleMed aims to enhance patient outcomes and streamline treatment processes.

Kriya Materials BV specializes in the development and manufacture of metal oxide nanoparticles, along with their downstream dispersions and functional coating products. Founded in 2006 and based in Geleen, the Netherlands, the company produces a variety of coatings, including hardcoat, anti-fouling, and solar heat coatings, which are designed to enhance energy efficiency and reduce environmental impact. These advanced coatings find applications across multiple industries, notably in the plasma panel and LCD sectors, serving products from smartphones to touch panels and glass surfaces. Kriya Materials' innovations focus on creating high-end coatings that utilize doped metal-oxide nanoparticles to effectively filter solar radiation, thereby minimizing heat gain and contributing to lower CO2 emissions.

Cristal Therapeutics BV is a clinical-stage pharmaceutical company based in Maastricht, the Netherlands, founded in 2011. The company specializes in developing nanomedicines using its proprietary CriPec platform, which transforms drugs into nanoparticles for targeted therapy. This advanced technology aims to enhance the efficacy of both new and existing drugs by improving their delivery to specific tissues and cells, thereby addressing significant medical needs, particularly in cancer treatment. Cristal Therapeutics focuses on creating versatile nanomedicine solutions that can facilitate better outcomes in various therapeutic areas through innovative polymeric constructs.

Matisse Pharmaceuticals B.V. is a biotechnology company based in Geleen, the Netherlands, specializing in the development of pharmaceutical therapies for sepsis and related inflammatory disorders. Founded in 2014, the company is advancing its lead product, M6229, a heparin fraction currently in the pre-clinical phase, aimed at treating severe sepsis and septic shock. Matisse Pharmaceuticals focuses on research and development efforts to create therapies that neutralize harmful components of the inflammatory system, ultimately enhancing treatment options for healthcare professionals and improving patient outcomes.

Fortimedix B.V., founded in 1999 and based in Nuth, the Netherlands, specializes in the development and manufacturing of endovascular, coronary, and peripheral stents. As a global leader in stent technology, the company has established a strong presence in the medical device industry, focusing on innovation and continuous improvement. With full in-house capabilities for stent development and production, Fortimedix is dedicated to operational excellence. The company prioritizes research and development to advance its technology and meet the evolving needs of its customers and stakeholders.

Materiomics B.V. is a biotech company based in the Netherlands that focuses on enhancing the functionality and durability of medical and cell culture devices through its innovative TopoChip technology. Founded in 2009, the company specializes in designing and identifying optimal surfaces that address various challenges related to anti-thrombosis, anti-encapsulation, pro-fixation, and cell growth. Materiomics aims to improve biological performance by optimizing the properties of polymer, metal, or ceramic surfaces, thereby reducing the risk of surgical implant rejection and enhancing overall device efficacy in medical applications.

Ioniqa Technologies BV is a chemical company based in Eindhoven, Netherlands, founded in 2009. It specializes in magnetic smart processes and offers a range of products including magnetic fluids, magnetic rubber, and magneto rheological gels. The company has developed a patented technology that utilizes magnetic colloidal systems with nanoparticles to efficiently break down PET into reusable monomers, effectively removing pigmentation and expanding the range of recyclable PET feedstock. Ioniqa's innovative platform aims to create value from plastic waste through proprietary circular technology, enabling sustainable plastic recycling and upcycling at competitive prices. In addition to its product offerings, Ioniqa provides consulting services to various sectors, including medical applications and art.

Black Bear Carbon BV specializes in converting waste tires into carbon black and green energy, operating primarily in the Netherlands and internationally. Founded in 2010 and based in Nederweert, the company utilizes a circular economy model to transform end-of-life tires into sustainable products. Its carbon black, a form of elemental carbon produced through controlled pyrolysis and partial combustion, is employed in various applications, including tires, technical rubber products, plastics, and paints. Additionally, Black Bear Carbon powers its tire shredding operations with electricity generated on-site, while also supplying excess energy to local industries and grids. By providing a renewable resource that reduces reliance on oil and lowers carbon dioxide emissions, the company promotes environmentally friendly practices in the manufacturing sector.

Cristal Therapeutics BV is a clinical-stage pharmaceutical company based in Maastricht, the Netherlands, founded in 2011. The company specializes in developing nanomedicines using its proprietary CriPec platform, which transforms drugs into nanoparticles for targeted therapy. This advanced technology aims to enhance the efficacy of both new and existing drugs by improving their delivery to specific tissues and cells, thereby addressing significant medical needs, particularly in cancer treatment. Cristal Therapeutics focuses on creating versatile nanomedicine solutions that can facilitate better outcomes in various therapeutic areas through innovative polymeric constructs.

Quality Circular Polymers specializes in providing high-quality circular polymer compounds derived from recycled plastics. The company focuses on sustainable recycling solutions for industrial waste, utilizing advanced compounding technology to transform used plastics into valuable materials. By developing an integrated recycling process, Quality Circular Polymers enables brand owners and plastics converters to reduce their reliance on fossil-based feedstock, thereby promoting a more sustainable approach to plastic use and waste management.

Enzypep, established in 2012 and headquartered in Geleen, Netherlands, specializes in the design and development of oligopeptides for pharmaceutical applications. The company utilizes its proprietary technologies, including Chemo Enzymatic Peptide Synthesis (CEPS) and Protein Enzymatic Conjugation (PECON), to create sustainable and cost-effective synthesis routes for pharmaceutical peptides and bioconjugates. Enzypep's innovative approach results in products of significantly higher purity compared to traditional synthesis methods, while also being environmentally friendly. By advancing peptide ligation technology, Enzypep aims to set a new standard in the preparation of complex peptides for the pharmaceutical industry.

Chemtrix BV specializes in providing complete and customized microreactor systems aimed at enhancing process efficiency, energy efficiency, and safety in chemical synthesis. The company offers a range of flow chemistry equipment, including standard glass microreactors and glass and ceramic reactors. These systems are designed for both research and development and commercial manufacturing, primarily serving the fine chemical and pharmaceutical industries. By facilitating the evaluation of reaction time and temperature effects, Chemtrix enables clients to explore new chemical possibilities, ultimately supporting their growth and profitability.